Profil
Paul V.
Drohan is currently the Chief Executive Officer at Zomanex LLC.
Previously, he served as the President & Chief Executive Officer at LifeSciences British Columbia.
Postes actifs de Paul V. Drohan
| Sociétés | Poste | Début |
|---|---|---|
Zomanex LLC
 Zomanex LLC Pharmaceuticals: MajorHealth Technology Zomanex LLC develops proprietary pharmaceutical products. It develops OraZom, a drug delivery platform that allows certain classes of large molecules to be converted from IV to oral administration. The company was founded on August 1, 2001 and is headquartered in Hendersonville, NC. | Directeur Général | - |
Anciens postes connus de Paul V. Drohan
| Sociétés | Poste | Fin |
|---|---|---|
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
Zomanex LLC
Zomanex LLC Pharmaceuticals: MajorHealth Technology Zomanex LLC develops proprietary pharmaceutical products. It develops OraZom, a drug delivery platform that allows certain classes of large molecules to be converted from IV to oral administration. The company was founded on August 1, 2001 and is headquartered in Hendersonville, NC. | Health Technology |
